Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
3(38%)

Phase Distribution

Ph not_applicable
7
88%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Terminated(3)

Detailed Status

Completed5
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
62.5%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (12.5%)
N/A7 (87.5%)

Trials by Status

completed563%
terminated338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8